Belgium – Healthcare, Regulatory and Reimbursement Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData, the industry analysis specialist, has released its latest report: “Belgium – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in Belgium. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Belgium pharmaceutical market was worth $7.90 in 2013, which increased to $8.00B in 2019 at a CAGR of 3.1%. The market value is expected to increase further to $8.10B by 2025. Belgium is a well-developed healthcare market in Western Europe with universal health coverage. Government initiatives such as eHealth 2019–2021 and Artificial Intelligence for Belgium (AI4Belgium) are intended to encourage the adoption of digital health solutions. Belgium's healthcare infrastructure, aging population, innovation-focused R&D investments in pharmaceutical companies, and increased prevalence of chronic diseases are attributed to the growth of the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Belgium, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, AstraZeneca, and UCB

Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Zimmer Biomet, Agfa-Gevaert NV, and IBA

An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Belgium healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Belgium’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Belgium’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the Belgium Healthcare Market

2.3 Key Highlights: Healthcare Startups in Belgium

2.4 Key Events: Belgium Healthcare Timeline, 2015–2021

2.5 Key Events: Belgium Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019–2020

2.7 Key Events: Top Completed Deals by Value, 2019–2020

2.8 Country Profile, Belgium, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Belgium

3.5 Pharmaceutical Market – Market Segments

3.6 Major Therapeutic Areas, Belgium

3.7 COVID-19 Epidemiology, Belgium

3.8 COVID-19 Impact and Developments in the Healthcare Market, Belgium

3.9 COVID-19 Clinical Trials Landscape, Belgium

3.10 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Belgium, 2019–2020

6.2 Deal Analysis: Medical Device Market, Belgium, 2019–2020

7. HealthTech Landscape

7.1 HealthTech Landscape, Belgium

7.2 HealthTech Deals Landscape, Belgium

7.3 Adoption of Technology in Healthcare, Belgium

7.4 Key HealthTech Deals, Belgium

7.5 Government-Sponsored Schemes Promoting Startups, Belgium

7.6 Regulatory Scenario Covering Use of Technology in Healthcare, Belgium

7.7 HealthTech Landscape: Benefits and Risks, Belgium

8. Market Access

8.1 Overview of Healthcare System, Belgium

8.2 Reimbursement Process, Belgium

8.3 Overview of Insurance Providers, Belgium

8.4 Healthcare Spending and Medicine Price Index, Belgium

8.5 Pricing Policies, Belgium

8.6 Regulatory Landscape, Belgium

8.6.1 Marketing Authorization for Pharmaceutical Products, EU

8.6.2 Marketing Authorization for Pharmaceutical Products, Belgium

8.6.3 Market Authorization for Medical Devices, Belgium

8.6.4 Exports and Parallel Imports, Belgium

8.6.5 Intellectual Property Rights, Patent, Belgium

8.6.6 Intellectual Property Rights, Trademarks, Belgium

8.6.7 Clinical Trial Regulation Process, Belgium

8.6.8 Pharmaceutical Clinical Trials Landscape, Belgium

8.6.9 Medical Devices Clinical Trials Landscape, Belgium

8.6.10 Pharmaceutical Export and Import, Belgium

8.6.11 Pharmaceutical Advertisement Regulations, Belgium

8.6.12 Pharmacy Regulations, Belgium

8.6.13 Labeling and Packaging Regulations, Belgium

9. Country Healthcare Landscape

9.1 Belgium Healthcare Policy Highlights

9.2 Healthcare Facilities, Belgium

9.3 Healthcare Parameters, Belgium

9.4 Life Expectancy and Immunization Rate, Belgium

9.5 Environmental Health, Belgium

9.6 Healthcare Personnel, Belgium

9.7 Disease Burden, Belgium

9.8 Healthcare Expenditure, Belgium

10 Trade Associations, Belgium

11 Trade Fairs, Belgium

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: Reimbursed Biosimilars, Belgium, 2019

Table 2: Pharmaceutical Market, Belgium, Sales of Patented Drug Products by Major Therapeutic Class ($M), 2019

Table 3: COVID-19 Indicators (Number of Cases), Global and Belgium, 2021

Table 4: COVID-19 In Vitro Diagnostics Products, Belgium, 2020–2021

Table 5: Medical Device Market, Belgium, Major Segments ($M), 2020

Table 6: Orthopedic Devices Market, Belgium, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 7: Cardiovascular Devices Market, Belgium, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 8: General Surgery Market, Belgium, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 9: Wound Care Management Market, Belgium, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 10: In Vitro Diagnostics Market, Belgium, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 11:Reimbursement Categories, Belgium, 2020

Table 12: Co-payments, Belgium, 2020

Table 13: Requirements for Parallel Import Authorization, Belgium, 2020

Table 14: Provisions for the Advertisement of Medicines (Human Use), Belgium, 2020

Table 15: Pharmacy License Requirements, Belgium, 2020

Table 16: Primary Package Label Information, Belgium, 2020

Table 17: Blister Package Label Information, Belgium, 2020

Table 18: Small Package Label Information, Belgium, 2020

Figures

Figure 1: Pharmaceutical Market, Belgium, Revenue ($B), 2013–2020

Figure 2: Medical Device Market, Belgium, Revenue ($B), 2015–2020

Figure 3: Healthcare Startups in Belgium, 2020

Figure 4: Number of Deals (2019–2020)

Figure 5: 2019–2020 Deal Overview by Region

Figure 6: Country Profile, Belgium, 2020

Figure 7: Pharmaceutical Market, Belgium, Revenue ($B), 2013–2019

Figure 8: Pharmaceutical Market, Belgium, Revenue Forecast ($B), 2020–2025

Figure 9: Pharmaceutical Exports ($B), Belgium, 2012–2019

Figure 10: Top Export Partners, Belgium, 2019

Figure 11: Pharmaceutical Imports ($B), Belgium, 2012–2019

Figure 12: Top Import Partners, Belgium, 2019

Figure 13: Pharmaceutical Supply Channel, Belgium, 2020

Figure 14: Generic Drugs Usage (% share by volume), Belgium, 2012–2018

Figure 15: Generic Drugs Usage (% share by value), Belgium, 2012–2018

Figure 16: OTC Market, Belgium, Revenue ($B), 2013–2019

Figure 17: OTC Market by Drug Category, Belgium, Revenue ($M), 2019

Figure 18: Pharmaceutical Market, Belgium, Sales of Patented Drug Products by Major Therapeutic Class, 2019

Figure 19: COVID-19 (Cases), Belgium, 2020–2021

Figure 20: COVID-19 (Deaths), Belgium, 2020–2021

Figure 21: COVID-19 Clinical Trials Count By Trial Status, Belgium, 2020–2021

Figure 22: COVID-19 Clinical Trials Count By Phase, Belgium, 2020–2021

Figure 23: Top Five COVID-19 Clinical Trials Sponsors By Count, Belgium, 2020–2021

Figure 24: Medical Device Market, Belgium, Revenue ($B), 2015–2020

Figure 25: Medical Device Market, Belgium, Revenue Forecast ($B), 2021–2025

Figure 26: Medical Device Market, Belgium, Major Segments (%), 2020

Figure 27: Orthopedic Devices Market, Belgium, Revenue ($M), 2017–2024

Figure 28: Orthopedic Devices Market, Belgium, Market Share of Major Players (%), 2019

Figure 29: Cardiovascular Devices Market, Belgium, Revenue ($M), 2017–2024

Figure 30: Cardiovascular Devices Market, Belgium, Market Share of Major Players (%), 2019

Figure 31: General Surgery Market, Belgium, Revenue ($M), 2017–2024

Figure 32: General Surgery Market, Belgium, Market Share of Major Players (%), 2019

Figure 33: Wound Care Management Market, Belgium, Revenue ($M), 2017–2024

Figure 34: Wound Care Management Market, Belgium, Market Share of Major Players (%), 2019

Figure 35: In Vitro Diagnostics Market, Belgium, Revenue ($M), 2017–2024

Figure 36: In Vitro Diagnostics Market, Belgium, Market Share of Major Players (%), 2018

Figure 37: Diagnostics Market, Belgium, Revenue ($M), 2015–2020

Figure 38: Diagnostics Market, Belgium, Revenue ($M), 2021–2025

Figure 39: Medical Devices Market, Revenue ($B) of Major Companies, Belgium, 2019

Figure 40: Deal Value and Deal Count, Pharmaceutical Market, Belgium, 2019–2020

Figure 41: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Belgium, 2019–2020

Figure 42: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Belgium, 2019–2020

Figure 43: Top Therapy Areas by Deal Value, Pharmaceutical Market, Belgium, 2019–2020

Figure 44: Top Therapy Areas by Deal Count, Pharmaceutical Market, Belgium, 2019–2020

Figure 45: Mergers and Acquisitions Deals by Quarter, Pharmaceutical Market, Belgium, 2019–2020 (by Value and by Number)

Figure 46: Venture Financing Deals by Quarter, Pharmaceutical Market, Belgium, 2019–2020 (by Value and by Number)

Figure 47: Deal Value and Deal Count, Medical Devices Market, Belgium, 2019–2020

Figure 48: Deal Value and Deal Count, Quarterly, Medical Devices Market, Belgium, 2019–2020

Figure 49: Deal Value and Deal Count Subtypes, Medical Devices Market, Belgium, 2019–2020

Figure 50: Top Equipment Sectors by Deal Value, Medical Devices Market, Belgium, 2019–2020

Figure 51: Top Equipment Sectors by Deal Count, Medical Devices Market, Belgium, 2019–2020

Figure 52: Venture Financing Deals by Equipment Sector, Medical Devices Market, Belgium, 2019–2020 (by value and by number)

Figure 53: Deal Value ($M), HealthTech, Belgium, 2019–2020

Figure 54: Deal Count ($M), HealthTech, Belgium, 2019–2020

Figure 55: HealthTech Ecosystem, 2020

Figure 56: INAMI Administrative Structure, Belgium, 2020

Figure 57: Drug Reimbursement Process, Belgium, 2020

Figure 58: Types of Reimbursement Claims, Belgium, 2020

Figure 59: OOP Expenditure (% of total expenditure on health), Belgium, 2012–2019

Figure 60: Annual Rate of Change (%), Health Price Index, Belgium, 2013–2019

Figure 61: Federal Agency for Medicines and Health Products, Organization Chart, Belgium, 2020

Figure 62: Marketing Authorization for Pharmaceutical Products, EU, 2020

Figure 63: Centralized Procedure, Belgium, 2019

Figure 64: Decentralized Procedure, Belgium, 2019

Figure 65: Mutual Recognition Procedure, Belgium, 2019

Figure 66: Conformity Assessment of Class I Medical Devices, EU, 2020

Figure 67: Conformity Assessment of Class IIa Medical Devices, EU, 2020

Figure 68: Conformity Assessment of Class IIb Medical Devices, EU, 2020

Figure 69: Conformity Assessment of Class III Medical Devices, EU, 2020

Figure 70: European Patent Approval Process, EU, 2020

Figure 71: Unitary Patent Approval Process, EU, 2020

Figure 72: Trademark Approval Process, Belgium, 2020

Figure 73: Clinical Trial Process, Regulation Approval Process Belgium, 2020

Figure 74: Pharmaceutical Clinical Trials Count By Trial Status, Belgium, 2019–2020

Figure 75: Pharmaceutical Clinical Trials Count By Indication, Belgium, 2019–2020

Figure 76: Pharmaceutical Clinical Trials Count By Phase, Belgium, 2019–2020

Figure 77: Top Five Pharmaceutical Clinical Trials Sponsors By Count, Belgium, 2019–2020

Figure 78: Medical Devices Clinical Trials Count by Trial Status, Belgium, 2019–2020

Figure 79: Medical Devices Clinical Trials Count by Indication, Belgium, 2019–2020

Figure 80: Medical Devices Clinical Trials Count by Category, Belgium, 2019–2020

Figure 81: Top Five Medical Devices Clinical Trial Sponsors by Count, Belgium , 2019–2020

Figure 82: Number of Hospitals, Belgium, 2013–2020

Figure 83: Number of Diagnostic Equipment, Belgium, 2015–2020

Figure 84: Number of Hospital Beds (per 1,000 Population), Belgium, 2013–2020

Figure 85: Number of Acute Care Beds (per 1,000 Population), Belgium, 2013–2020

Figure 86: Number of Psychiatric Care Beds (per 1,000 Population), Belgium, 2013–2020

Figure 87: Life Expectancy at Birth (Years), Belgium, 2013–2020

Figure 88: Immunization Rate (%), Belgium, 2012–2019

Figure 89: CO2 Emissions (Million Tons), Belgium, 2013–2020

Figure 90: PM2.5 (µg per m3), Belgium, 2013–2020

Figure 91: Physicians (per 1,000 Population), Belgium, 2013–2020

Figure 92: Dentists (per 1,000 Population), Belgium, 2013–2020

Figure 93: Pharmacists (per 1,000 Population), Belgium, 2013–2020

Figure 94: Nurses (per 1,000 Population), Belgium, 2013–2020

Figure 95: Major Causes of Mortality (per 1,000 population), Belgium, 2016

Figure 96: Major Causes of Male Mortality (per 1,000 population), Belgium, 2016

Figure 97: Major Causes of Female Mortality (Per 1,000 Population), Belgium, 2016

Figure 98: Disability-Adjusted Life Years by Major Disease (Per 1,000 Population), Belgium, 2016

Figure 99: Healthcare Expenditure as Percentage of GDP (%), Belgium, 2013–2020

Figure 100: Public–Private Share (%), Belgium, 2013–2020

Figure 101: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Belgium, 2018

Figure 102: Pharmaceutical Spending ($ Per Capita), Belgium, 2010–2018

Frequently asked questions

Belgium – Healthcare, Regulatory and Reimbursement Landscape thematic reports
Currency USD
$1,995

Can be used by individual purchaser only

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Belgium – Healthcare, Regulatory and Reimbursement Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Belgium – Healthcare, Regulatory and Reimbursement Landscape in real time.

  • Access a live Belgium – Healthcare, Regulatory and Reimbursement Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.